Clinical Trials Directory

Trials / Completed

CompletedNCT01072292

Cognitive Behavioral Therapy for Insomnia in People With Chronic Obstructive Pulmonary Disease(COPD)

Nurse Managed Cognitive Behavioral Therapy for Insomnia in People With Chronic Obstructive Pulmonary Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
University of Illinois at Chicago · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

A two-phase research study is being conducted. In Phase 1 of the study, the cognitive behavioral therapy intervention for insomnia was implemented in a small (n = 5) group of people with moderate to severe COPD and insomnia. The intervention was pilot-tested to determine feasibility and acceptability, and the intervention will be refined as needed. In Phase 2 of the study, a two-group randomized controlled study (n = 20) will be conducted to test the effects of the cognitive behavioral therapy for insomnia intervention on the primary outcomes of sleep quality and fatigue and the secondary outcomes of mood and functional performance. It is hypothesized that people with COPD receiving cognitive behavioral therapy for insomnia will demonstrate significant improvements in sleep quality, fatigue, mood and functional performance as compared to people with COPD who receive a wellness program. This research will yield valuable information regarding effective interventions aimed at mitigating problems such as poor sleep quality, fatigue and reduced ability to perform valued daily activities. This information will be used to increase the likelihood of long-term successful outcomes such as the ability to maintain productive roles in society for people with COPD.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCBT-ICBT-I is a six week program designed to improve sleep quality in people with COPD.

Timeline

Start date
2008-06-01
Primary completion
2011-06-01
Completion
2011-06-01
First posted
2010-02-22
Last updated
2014-06-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01072292. Inclusion in this directory is not an endorsement.